Directori de persones
Anna Macia Armengol

Anna Macia Armengol

Grau: Doctor/a

3750
anna.macia(ELIMINAR)@udl.cat

ResearcherID: http://www.researcherid.com/rid/V-2631-2017

Grups

Publicacions

  • Alberti-Valls, M; Olave, S; Olomí, A; Macià, A; Eritja, N

    Advances in Immunotherapy for Endometrial Cancer: Insights into MMR Status and Tumor Microenvironment

    Cancers 16 -. .

    [doi:10.3390/cancers16233918]

  • Millán-Esteban, D; García-Casado, Z; Macià, A; de la Rosa, I; Torrecilla-Vall-Llossera, C; Penín, RM; Manrique-Silva, E; Pellegrini, S; Biasin, MR; Rizzolo, P; Gavillero, A; Di Stefani, A; Pellegrini, C; Requena, C; Fargnoli, MC; Peris, K; Cota, C; Menin, C; Landi, MT; Nagore, E

    Molecular Profile of Subungual Melanoma: a MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT promoter status.

    Dermatology 240 164-169. .

    [doi:10.1159/000534955]

  • Albertí-Valls M; Megino-Luque C; Macià A; Gatius S; Matias-Guiu X; Eritja N

    Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.

    Cancers 16 -. .

    [doi:10.3390/cancers16010185]

  • Sisó, P; de la Rosa, I; Rios, C; Panosa, A; Verdaguer, J; Martí, R; Macià, A

    Protocol to characterize the melanoma tumor immune microenvironment in mice from single cell to flow cytometry analysis

    Star Protocols 4 102690-102690. .

    [doi:10.1016/j.xpro.2023.102690]

  • Pijuan J; Macià A; Panosa A

    Live Cell Adhesion, Migration, and Invasion Assays.

    Methods in molecular biology (Clifton, N.J.) 2644 313-329. .

    [doi:10.1007/978-1-0716-3052-5_20]

  • Barcelo, C.; Siso, P.; de la Rosa, I.; Megino-Luque, C.; Navaridas, R.; Maiques, O.; Urdanibia, I.; Eritja, N.; Soria, X.; Potrony, M.; Calbet-Llopart, N.; Puig, S.; Matias-Guiu, X.; Marti, R. M.; Macia, A.

    M-CSF as a therapeutic target in BRAF(V600E) melanoma resistant to BRAF inhibitors.

    BRITISH JOURNAL OF CANCER 127 1142-1152. .

    [doi:10.1038/s41416-022-01886-4]

  • Altes, G; Vaquero, M; Cuesta, S; Anerillas, C; Macia, A; Espinet, C; Ribera, J; Bellusci, S; Klein, OD; Yeramian, A; Dolcet, X; Egea, J; Encinas, M

    A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes

    Cellular And Molecular Life Sciences 79 514-514. .

    [doi:10.1007/s00018-022-04546-1]

  • Megino-Luque, Cristina; Siso, Pol; Mota-Martorell, Natalia; Navaridas, Raul; de la Rosa I; Urdanibia, Izaskun; Alberti-Valls, Manel; Santacana, Maria; Pinyol, Miquel; Bonifaci, Nuria; Macia, Anna; Llobet-Navas, David; Gatius, Sonia; Matias-Guiu, Xavier; Eritja, Nuria

    ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

    MOLECULAR ONCOLOGY 16 2235-2259. .

    [doi:10.1002/1878-0261.13193]

  • MORENO, S; MAIQUES, O; Romero M; Santacana M; Gómez I; Cuevas D; Velasco A; Veà À; Macià A; Barceló C; BOIX, R; VALLS, J; GATIUS, S; CANTI, C; MATIAS-GUIU, X; SORIA, X; MARTI, RM

    Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification.

    ACTA DERMATO-VENEREOLOGICA 101 -. .

    [doi:10.2340/actadv.v101.361]

  • Soria X; Vilardell F; Maiques Ó; Barceló C; Sisó P; de la Rosa I; Velasco A; Cuevas D; Santacana M; Gatius S; Matías-Guiu X; Rodrigo A; Macià A; Martí RM

    BRAF(V600E)

    Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics

    Cancers 13 -. .

    [doi:10.3390/cancers13205073]

  • Barcelo, C; Siso, P; Maiques, O; de la Rosa, I; Marti, RM; Macia, A

    T-type calcium channels: A potential novel target in melanoma

    Cancers 12 -. .

    [doi:10.3390/cancers12020391]

  • Barceló C; Sisó P; Maiques O; García-Mulero S; Sanz-Pamplona R; Navaridas R; Megino C; Felip I; Urdanibia I; Eritja N; Soria X; Piulats JM; Penin RM; Dolcet, X; Matias-Guiu, X; Marti, RM; Macia, A

    T-Type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAF V600E melanoma: TTCCs are therapy target in BRAF V600E melanoma.

    JOURNAL OF INVESTIGATIVE DERMATOLOGY 140 1253-1265. .

    [doi:10.1016/j.jid.2019.11.014]

Projectes

  • Immunophenotyping of Cholangiocarcinoma using Liquid Biopsy
  • OncoNeoVac, un nuevo enfoque inmunoterapéutico para el tratamiento del melanoma.
  • Análisis del microambiente tumoral del melanoma cutáneo asociado al perfil genético y/o a la aparición de resistencias
  • Análisis del secretoma en el melanoma humano asociado al perfil genético y a la aparición de resistencias. Identificación de biomarcadores y/o dianas terapéuticas de aplicación clínica
  • POSTDOCTORAL AECC 2017: ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA HUMANO. ESTUDIO DE LAS RESISTENCIAS A FARMACOS CONVENCIONALES Y EL PROCESO AUTOFAGICO
  • ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
  • IMPLEMENTATION OF PERSONALIZE MEDICINE IN CUTANEOUS MELANOMA BASED ON GENOMIC SUSCEPTIBILITY AND TUMOR SIGNATURES: IDENTIFICATION OF NEW TARGETS FOR MELANOMA TREATMENT
  • A ROLE FOR RET SIGNALING IN SMITH-LEMLI-OPITZ SYNDROME